The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
Open accessAbstract
Regulatory T cells are believed to control the development and progression of autoimmunity by suppressing autoreactive T cells. Decreased numbers of CD4(+)CD25(+) FOXP3(+) T cells (Tregs) are associated with impaired immune homeostasis and development of autoimmune diseases. The transcription factors FOXP3 and NFAT1 have key roles in regulatory T-cell development and function. We show that Tregs are decreased at presentation in almost all patients with aplastic anemia; FOXP3 protein and mRNA levels also are significantly lower in patients with aplastic anemia and NFAT1 protein levels are decreased or absent. Transfection of FOXP3-deficient CD4(+)CD25(+) T cells from patients with a plasmid encoding wild-type NFAT1 resulted in increased FOXP3 expression in these cells. By NFAT1 knockdown in CD4(+)CD25(+) T cells, FOXP3 expression was decreased when NFAT1 expression was decreased. Our findings indicate that decreased NFAT1 could explain low FOXP3 expression and diminished Treg frequency in aplastic anemia. Treg defects are now implicated in autoimmune marrow failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another major effector of damage is a type 1 T-helper (Th1) cell-skewed response of the adaptive immune system, which was also identified as the major source of IFN-g, accompanied by a reduction in regulatory T cells (Tregs) in the marrow.60”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,229
Current concepts in the pathophysiology and treatment of aplastic anemia
Young, N. S., Calado, R. T., & Scheinberg, P. (2006) · Blood · doi:10.1182/blood-2006-03-010777 · Cited by 888
Self-citationRegulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
Wan, Y. Y., & Flavell, R. A. (2007) · Nature · doi:10.1038/nature05479 · Cited by 876
Toll-like receptor 2 controls expansion and function of regulatory T cells
Sutmuller, R. P. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25439 · Cited by 750
Beyer, M., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2006-02-002774 · Cited by 741
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells
Shevach, E. M., DiPaolo, R. J., Andersson, J., Zhao, D., Stephens, G. L., & Thornton, A. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00415.x · Cited by 589
Gambineri, E., Torgerson, T. R., & Ochs, H. D. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00010 · Cited by 575
Cited by
Sorted by citations
Items 101–200 of 225
Wang, W., Luo, D., Chen, J., Chen, J., Xia, Y. X., Chen, W., & Wang, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20201350 · Cited by 16
Lan, Y., Liu, F., Chang, L., Liu, L., Zhang, Y., Yi, M., Cai, Y., Feng, J., Han, Z., Han, Z., et al. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02562-x · Cited by 16
Fujiwara, T., Yokoyama, H., Okitsu, Y., Kamata, M., Fukuhara, N., Onishi, Y., Fujimaki, S., Takahashi, S., Ishizawa, K., Bresnick, E. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040959 · Cited by 16
Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia
Takaku, T., Calado, R. T., Kajigaya, S., & Young, N. S. (2009) · Annals of Hematology · doi:10.1007/s00277-008-0666-6 · Cited by 16
Self-citationDanazol increases T regulatory cells in patients with aplastic anemia
Khurana, H., Malhotra, P., Sachdeva, M. U. S., Varma, N., Bose, P. L., Yanamandra, U., Varma, S. C., Khadwal, A., Lad, D. P., & Prakash, G. (2018) · Hematology · doi:10.1080/10245332.2018.1435045 · Cited by 16
Lan, H., Qiu, W., Wu, J., Hu, Z., Zhang, X., & Zhu, L. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00919-9 · Cited by 15
High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia
Gamper, C. J., Takemoto, C. M., Chen, A. R., Symons, H. J., Loeb, D. M., Casella, J. F., Dezern, A. E., King, K. E., McGonigle, A. M., Jones, R. J., et al. (2016) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000647 · Cited by 15
Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells
Brzeźniakiewicz‐Janus, K., Rupa‐Matysek, J., & Gil, L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09971-y · Cited by 17
Tang, D.-B., Liu, S., Sun, H., Qin, X., Zhou, N., Zheng, W., Zhang, M., Zhou, H., Abudureheman, T., Duan, C., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16871 · Cited by 15
Sevilla, D. W., Emmons, F. N., Colovai, A. I., Beaubier, N. T., Baker, C., Bhatia, M., Bhagat, G., & Alobeid, B. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903156737 · Cited by 15
Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility
Wang, X., Li, J., Wu, K., Yang, S., & Chao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054464 · Cited by 14
Xiao, Z., Wang, S., Chen, J., Li, Y., Jiang, Y., Tin, V. P., Liu, J. S., Hu, H., Wong, M. P., Pan, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202306059 · Cited by 14
Wang, C., Zhang, T., Wang, Y., Li, Y., Liu, C., Liu, H., Li, L., Ding, K., Wang, T., Wang, H., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8014 · Cited by 14
Kamhawi, H., Huang, W., Haag, T., & Spektor, R. (2014) · NASA Technical Reports Server (NASA) · Cited by 14
Gurnari, C., & Visconte, V. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107038 · Cited by 13
Self-citationPhase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes
Kadia, T. M., Huang, M., Pemmaraju, N., Abbas, H. A., Ly, C. P., Masárová, L., Yilmaz, M. E., Lyu, M.-A., Zeng, K., Sadeghi, T., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2300362 · Cited by 13
Ishii, K., & Young, N. S. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.07.002 · Cited by 13
Self-citationImmune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?
Samarasinghe, S., Marsh, J. C. W., & Dufour, C. (2014) · Haematologica · doi:10.3324/haematol.2014.105569 · Cited by 13
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease
Luzzatto, L., & Karadimitris, A. (2020) · British Journal of Haematology · doi:10.1111/bjh.17147 · Cited by 12
(Auto-)immune signature in aplastic anemia
Risitano, A. M. (2018) · Haematologica · doi:10.3324/haematol.2018.190884 · Cited by 13
Infectious Agents and Bone Marrow Failure: A Causal or a Casual Connection?
Giudice, V., Risitano, A. M., & Selleri, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757730 · Cited by 12
Pillai, A. B., Hartford, C. M., Wang, C., Pei, D., Yang, J., Srinivasan, A., Triplett, B. M., Dallas, M. H., & Leung, W. H. (2011) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2011.01542.x · Cited by 12
Badyal, R. K., Sachdeva, M. U. S., Varma, N., & Thapa, B. R. (2014) · Pediatric and Developmental Pathology · doi:10.2350/14-05-1489-cr.1 · Cited by 12
Visconte, V., Raghavachari, N., Liu, D., Keyvanfar, K., Desierto, M. J., Chen, J., & Young, N. S. (2009) · Haematologica · doi:10.3324/haematol.2009.011650 · Cited by 12
Self-citationAnti-inflammatory effects of interleukin-35 in acquired aplastic anemia
Yu, W., Ge, M., Lu, S., Shi, J., Li, X., Zhang, J., Wang, M., Huang, J., Shao, Y., Huang, Z., et al. (2015) · Cytokine · doi:10.1016/j.cyto.2015.08.004 · Cited by 11
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
Konishi, A., Nakaya, A., Fujita, S., Satake, A., Nakanishi, T., Azuma, Y., Tsubokura, Y., Saito, R., Hotta, M., Yoshimura, H., et al. (2019) · Leukemia Research Reports · doi:10.1016/j.lrr.2019.03.002 · Cited by 11
Increased T cell immunoglobulin mucin‐3 and its ligand in acquired aplastic anemia
Zhang, J., Gu, Y., Xu, C.-G., & Qu, X. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01095.x · Cited by 11
Association of aplastic anemia andFoxP3gene polymorphisms in Koreans
In, J. W., Lee, N., Roh, E. Y., Shin, S., Park, K. U., & Song, E. Y. (2016) · Hematology · doi:10.1080/10245332.2016.1238645 · Cited by 11
Roles of regulatory T cells in the pathogenesis of pediatric aplastic anemia
Lin, S., Hou, L., Liu, S., Wang, J., Chen, Q., Zhang, B., Xue, H., Huang, J., & Chen, C. (2019) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2019.1621968 · Cited by 12
Yu, W., Ge, M., Lu, S., Shi, J., Feng, S., Li, X., Zhang, J., Wang, M., Huang, J., Shao, Y., et al. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12628 · Cited by 10
The role of TIM3+ NK and TIM3- NK cells in the immune pathogenesis of severe aplastic anemia
Ding, S., Zhang, T., Lei, Y., Liu, C., Liu, Z., & Fu, R. (2024) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0104 · Cited by 9
Liu, B., Chen, W., Jiang, J., Zhou, W., Zhang, Y., He, R., Wang, Y., Liang, D., Liang, D., Chen, J., et al. (2019) · Physical Therapy · doi:10.1093/ptj/pzz074 · Cited by 9
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent
Aggarwal, N., Manley, A. L., Chen, J., Groarke, E. M., Feng, X., & Young, N. S. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.07.004 · Cited by 9
Self-citationAssessing the prognostic impact of immune cell infiltrates in follicular lymphoma
Fend, F., & Quintanilla-Martinez, L. (2014) · Haematologica · doi:10.3324/haematol.2014.104968 · Cited by 9
Vaht, K., Brenner, J., Ednersson, S. B., Ljungman, P. T., Brune, M. L., & Andersson, P. (2022) · European Journal Of Haematology · doi:10.1111/ejh.13908 · Cited by 9
Dysregulated T-cell homeostasis and decreased CD30+ Treg proliferating in aplastic anemia
Sun, N., Zhang, M., Kong, J., Li, J., Dong, Y., Wang, X., Fu, L., Zhou, Y., Chen, Y., Li, Y., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35775 · Cited by 8
Increased age-associated B cells in patients with acquired aplastic anemia correlate with IFN-γ
Solomou, E. E., Kattamis, A., Symeonidis, A. S., Sirinian, C., Salamaliki, C., Tzanoudaki, M., Diamantopoulos, P. T., Plakoula, E., Palassopoulou, M., Giannakoulas, N. C., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010109 · Cited by 8
Self-citationIdiopathic Aplastic Anemia: An Update
Solomou, E. E. (2019) · Clinical Hematology International · doi:10.2991/chi.d.190321.002 · Cited by 8
Self-citationLIU, N., LIU, J.-Q., LIU, Y., ZHU, Q., ZHENG, D., LI, F., Meng, L., & Qiu, M. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320220672 · Cited by 8
Qi, W., Ren, Y., Fu, R., Wang, H., Liu, C., & Shao, Z. (2015) · Turkish Journal of Hematology · doi:10.4274/tjh.2013.0410 · Cited by 8
Wu, Z., Gao, S., Feng, X., Li, H., Sompairac, N., Jamshidi, S., Choy, D., Reis, R. A. D., Gao, Q., Kajigaya, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60213-6 · Cited by 7
Self-citationTGF-β inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia
Zhang, X., Guo, L., Wang, Y., Jia, J., Mi, L., Shen, M.-Z., Wang, Z., Zhang, Z., Li, C., Lyu, Z., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01483-4 · Cited by 7
Zhang, L., Mao, J., Lian, Y., Liang, Q., Li, W., Zhao, J., Pan, H., Gao, Z., Fang, L., Yuan, W., et al. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05097-6 · Cited by 7
Role of vitamin D receptor gene polymorphisms in aplastic anemia: a case–control study from China
Yu, W., Ge, M., Shi, J., Li, X., Zhang, J., Wang, M., Shao, Y., & Zheng, Y. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12480 · Cited by 7
TRAIL in CD8+ T cells from patients with severe aplastic anemia
Liu, C., Zheng, M., Zhang, T., Fu, R., Wang, H., Wang, T., Qi, W., & Shao, Z. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2279-0 · Cited by 7
Involvement of interleukin‐21 in the pathophysiology of aplastic anemia
Zhang, J., Wu, Q., Shi, J., Ge, M., Li, X., Shao, Y., Yao, J., & Zheng, Y. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12471 · Cited by 7
Dioscin alleviates aplastic anemia through regulatory T cells promotion
Fan, L., Ni, R., Wang, H., Zhang, L., Wang, A., & Liu, B. (2024) · Hematology · doi:10.1080/16078454.2024.2326389 · Cited by 6
Deletion of Fanca or Fancd2 dysregulates Treg in mice
Du, W., Erden, O., Wilson, A., Sipple, J., Schick, J. S., Mehta, P. A., Myers, K. C., Steinbrecher, K. A., Davies, S. M., & Pang, Q. (2014) · Blood · doi:10.1182/blood-2013-09-528018 · Cited by 6
Abnormalities in Th17 T cells in aplastic anemia
Platanias, L. C. (2010) · Blood · doi:10.1182/blood-2010-09-305367 · Cited by 6
CD56bright natural killer cells exhibit abnormal phenotype and function in severe aplastic anemia
Chen, T., Liu, C., Li, L., Liu, H., Wang, T., Shao, Z., & Fu, R. (2019) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12982 · Cited by 6
Fang, J., Lin, L., Wang, Y., Lin, D., Liu, C., Sunlong, Q., & Lin, X. (2018) · Hematology · doi:10.1080/10245332.2018.1498566 · Cited by 6
Regulatory T Cell Therapy for Autoimmune Disease
Ha, T.-Y. (2008) · Immune Network · doi:10.4110/in.2008.8.4.107 · Cited by 6
Marsh, J. C. W., & Young, N. S. (2010) · doi:10.1002/9781444323160.ch13 · Cited by 6
Self-citationDuan, K., Zhang, B., Zhang, W., Zhao, Y., Qu, Y., Sun, C., & Zhao, Y. X. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.08.003 · Cited by 5
Analysis of fecal microbiome in Chinese patients with non-severe aplastic anemia
Zhang, X., Xie, J., Wang, H., & Li, J. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06459-y · Cited by 5
Recursive Partitioning to Differentiate Acquired From Inherited Bone Marrow Failure Syndromes
Kaphan, É., Walter‐Petrich, A., Larcher, L., Leblanc, T. M., Bruno, B., Forcade, É., Renard, C., Sterin, A., Loschi, M. L., Lainey, É., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.70064 · Cited by 5
Salvage therapy of refractory severe aplastic anemia by decreasing cyclosporine dose regimen
Bertrand, A., Philippe, M., Bertrand, Y., Plantaz, D., & Bleyzac, N. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12220 · Cited by 5
Evaluation of Anemia, Leukopenia, and Thrombocytopenia
Wilson, C. S., & Brynes, R. K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7216-0040-6.00011-3 · Cited by 5
Feng, X., Solomou, E. E., Keyvanfar, K., Herndon, T. M., Chen, J., Kajigaya, S., & Young, N. S. (2007) · Blood · doi:10.1182/blood.v110.11.2312.2312 · Cited by 5
Self-citationGhanei-Shahmirzadi, A., Reihani, H., Abbasi-Kashkooli, A., Karbasian, F., Hedayati, S. B., Bordbar, M., Ataollahi, M., Dehghani, S. M., & Geramizadeh, B. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03542-0 · Cited by 5
Immunophenotyping of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Illingworth, A. J., Marinov, I., & Sutherland, D. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9650-6_18 · Cited by 5
Zhao, J., Song, Y., Liu, L., Yang, S., & Fang, B. (2020) · Medicine · doi:10.1097/md.0000000000020630 · Cited by 5
Du, Y., Huang, Y., Zhou, W., Liu, X., Chen, F., Yang, C., Chen, M., Ruan, J., & Han, B. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s275975 · Cited by 5
Philippe, M., Hénin, É., Bertrand, Y., Plantaz, D., Goutelle, S., & Bleyzac, N. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9779-8 · Cited by 5
Role of miRNAs in T‐cell activation and Th17/Treg‐cell imbalance in acquired aplastic anemia
Sabreen, G., Rahman, K., Gupta, R., Chaturvedi, C. P., Srivastava, J., Chandra, D., Singh, M. K., Yadav, S., Sharma, A., Sarkar, M. K., et al. (2024) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.14243 · Cited by 6
Origins of T‐cell‐mediated autoimmunity in acquired aplastic anaemia
Enache, A., Carty, S. A., & Babushok, D. V. (2025) · British Journal of Haematology · doi:10.1111/bjh.19993 · Cited by 5
Umbilical Cord Blood‐Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
Chen, Z., Yang, C., Jiang, J., Chen, M., & Han, B. (2024) · Stem Cells International · doi:10.1155/2024/4095268 · Cited by 4
Wang, J., Zhou, R., Zhong, L., Chen, Y., Wu, X., Huang, L., Tian, Y., Mo, W., Wang, S., & Liu, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111163 · Cited by 4
Immunosuppressive Therapy for Aplastic Anemia
Marsh, J. C. W., Gandhi, S., & Mufti, G. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804152-9.00006-3 · Cited by 4
Oligoclonality and subpopulation structure of bone marrow T-cells in patients with aplastic anaemia
Abramova, A. V., Galtseva, I. V., Mikhaylova, E. A., Михайлович, К. Н., Davydova, Y. O., Таймуразовна, Ф. З., Troitskaya, V. V., Parovichnikova, E. N., & Vg, S. (2020) · Гематология и трансфузиология · doi:10.35754/0234-5730-2020-65-4-417-430 · Cited by 3
Platelets from patients with myocardial infarction can activate T cells
Solomou, E. E., Katsanaki, K., Kalyvioti, E., Gizas, V., Perperis, A., Babali, D., Verigou, E., Gogos, H., Hahalis, G. N., Davlouros, P. A., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.243402 · Cited by 3
Self-citation(2018) · Elsevier eBooks · doi:10.1016/b978-0-323-39254-9.50028-3 · Cited by 3
The impact of clonal hematopoiesis on outcomes in patients with aplastic anemia
Brzeźniakiewicz‐Janus, K., Rupa‐Matysek, J., Hoppe, A., & Gil, L. (2021) · Acta Haematologica Polonica · doi:10.5603/ahp.a2021.0026 · Cited by 2
An update on Acquired Aplastic Anemia
Solomou, E. E. (2017) · Hematology & Transfusion International Journal · doi:10.15406/htij.2017.04.00080 · Cited by 2
Self-citationWhy do Tregs suddenly disappear in aplastic anemia?
Scheinberg, P. (2020) · Blood · doi:10.1182/blood.2020006446 · Cited by 2
Alterations in Hematopoietic Microenvironment in Patients with Aplastic Anemia
Shipounova, I. N., Petrova, T. V., Svinareva, D. A., Momotuk, K. S., Mikhailova, E. A., & Дризе, Н. И. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00074.x · Cited by 2
The immune-mediated pathogenesis and treatment of aplastic anemia
Shinohara, K. (2012) · The bulletin of the Yamaguchi Medical School/Bulletin of the Yamaguchi Medical School · Cited by 2
Wang, X., Lin, Z., Liu, H., Lu, W., Liu, H., Lu, W., & Qian, Y. (2015) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2015.08.013 · Cited by 2
Solorzano, S., Kim, J., Chen, J., Feng, X., & Young, N. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248343 · Cited by 2
Self-citationRen, M., Ge, Y., Qi, J., Xue, S., Miao, M., Wu, D., Huang, Y., & Wang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-147288/v1 · Cited by 2
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia
Scala, P., Giudice, V., Morini, D., Corte, A. M. D., Selleri, C., & Serio, B. (2025) · Current Medical Science · doi:10.1007/s11596-025-00100-9 · Cited by 1
To c or not to c-KIT?: High toxicity and modest efficacy in CD117-directed CAR T cell therapy
Gannon, I., Roddie, C., & Rampotas, A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.021 · Cited by 1
Huang, C., Li, S., Yang, J., Jiao, Y., Zhang, T., Jiang, H., Zeng, F., & 蒋莎义 (2026) · Blood Research · doi:10.1007/s44313-026-00141-6 · Cited by 2
Abuljadayel, I. S., Mohanty, D., & Suri, R. K. (2012) · Europe PMC (PubMed Central) · Cited by 1
Emerging New Therapies for Acquired Bone Marrow Failure Disorders
Risitano, A. M., & de Latour, R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804152-9.00013-0 · Cited by 1
After Moving of Regulatory T-Cell Therapy to the Clinic: Will We Need a New Tregs Source?
Elbadry, M. I. (2017) · Hematology & Transfusion International Journal · doi:10.15406/htij.2017.05.00117 · Cited by 1
Lo, C. Y., Glader, A. B., & Sakamoto, K. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-53045-3.00028-3 · Cited by 1
Treatment of Severe Aplastic Anemia with Porcine Anti-Human Lymphocyte Globulin
Lv, Q., Zhang, H.-Q., Xiao, N., Liu, C., Shao, Z., & Wang, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200317131940 · Cited by 1
Regulatory cells in immune‐mediated aplastic anaemia – not Tregs but Bregs
Kulasekararaj, A. G. (2020) · British Journal of Haematology · doi:10.1111/bjh.16713 · Cited by 1
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
Khaddour, K., Harrison, N., Govindan, A., & Campian, J. L. (2020) · Case Reports in Oncology · doi:10.1159/000509744 · Cited by 1
Choi, H., Shin, M., Kim, H.-R., Kim, H., Kook, H., Kee, S., Kim, S., Shin, J. H., Suh, S., & Ryang, D. (2009) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2009.29.4.269 · Cited by 1
Young, N. S., Scheinberg, P., & Calado, R. T. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32830c6d12 · Cited by 1
Self-citationCurrent Research in CD4+CD25+ Regulatory T Cells and Autoimmune Diseases
罗, 晨. (2015) · Medical Diagnosis · doi:10.12677/md.2015.52005
The immune response dis-regulation and the pathogenesis of hematopoietic disorders
Sica, M. (2008) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/2817
A review on pathophysiology and treatment of aplastic anaemia
Nayak, J. (2014) · Journal of Drug Discovery and Therapeutics
Activated lymphocytes and monocytes in myelodysplastic syndromes
Meers, S. (2008)
Aplastic anemia and pure red cell aplasia
Gordon‐Smith, E. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00013-4
Pathophysiology of Acquired Bone Marrow Failure
Hosokawa, K. T., Scheinberg, P., & Young, N. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804152-9.00002-6
Self-citationA case of aplastic anemia after thymothymectomy
Kajiura, K., Sakiyama, S., Kondo, K., Toba, H., Takizawa, H., & Tangoku, A. (2017) · The Journal of the Japanese Association for Chest Surgery · doi:10.2995/jacsurg.31.815
Metadata
- Authors
- Solomou, E. E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A. J., & Young, N. S.
- Affiliations
- Hematology Branch and
- National Institutes of Health (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-09-01
- Volume
- 110
- Issue
- 5
- Pages
- 1603-1606
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC1975843
- OpenAlex
- W2066935327
- Cited by
- 225
- References
- 24
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 7 · 2021: 11 · 2020: 21 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 10 · 2012: 11
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- regulatory T cells, CD4+CD25+ T cells, Foxp3, NFAT1, acquired aplastic anemia, Treg deficiency, immune homeostasis, transcription factors, Treg reprogramming
- MeSH terms
- Adolescent, Adult, Anemia, Aplastic, Autoimmune Diseases, Cells, Cultured, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Transfection, Autoimmunity, T-Lymphocytes, Regulatory, NFATC Transcription Factors, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review